EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›VREX

VREX

Varex Imaging Corp

Next earnings Aug 5, 2026 · consensus $0.21 EPS, $219M rev

Last earnings -2.8% on 2026-05-07

Sell
$10.29
▲ 0.00%
$10.29▲ +31.42%
over 1Y
L $6.96EODHDH $14.36
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+0.0%
1W-1.1%
1M+0.8%
3M-4.1%
YTD-11.7%
1Y+31.4%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Sell
Quality
C-
Valuation
Fair value
Filings
Flagged
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 11 analysts
Buy

Unprofitable (net margin -8.3%).

Revenue (FY2025) $845M · FY2025

Varex Imaging Corp shows $845M in FY2025 revenue (+4.1% YoY), a -8.3% net margin, and -14.9% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$818M$859M$893M$811M$845M
Gross profit$272M$284M$290M$257M$291M
Operating income$74.1M$88.2M$77.1M$32.1M-$27.8M
Net income$17.4M$30.3M$47.4M-$48.8M-$70.3M
Diluted EPS$0.43$0.73$1.07-$1.20-$1.70
Net margin2.1%3.5%5.3%-6.0%-8.3%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$652M
EV / EBITDA—
EV / Sales0.8
EV / FCF34.7
P / FCF22.8
PEG (trailing)—
Earnings yield-16.4%
FCF yield4.4%

Quality & risk

ROIC (est.)-2.6%
Free cash flow$18.8M
Total debt$368M
Net cash-$223M
Altman Z-Score1.58 distress
Piotroski F-Score5/9

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+1.5%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Red flag in recent filings — agreement terminated (2026-03-16). Worth a closer look.
  1. 8-K Earnings results2026-05-07
  2. 10-Q Quarterly report2026-05-07
  3. 8-K Agreement terminated2026-03-16
  4. 8-K Shareholder vote2026-02-13
  5. 8-K Earnings results2026-02-10
  6. 10-Q Quarterly report2026-02-10
  7. DEF 14A Proxy statement2025-12-29
  8. 8-K Earnings results2025-11-18
  9. 10-K Annual report2025-11-18

Recent filings

all on EDGAR ↗
SDFiling2026-05-28open ↗10-QPeriod ending 2026-04-032026-05-07open ↗8-KPeriod ending 2026-05-072026-05-07open ↗3Period ending 2026-02-132026-03-27open ↗SCHEDULE 13G/AFiling2026-03-27open ↗3Period ending 2026-02-132026-03-26open ↗4Period ending 2026-03-202026-03-23open ↗144Filing2026-03-20open ↗8-KPeriod ending 2026-03-132026-03-16open ↗8-KPeriod ending 2026-02-122026-02-13open ↗4Period ending 2026-02-122026-02-13open ↗4Period ending 2026-02-122026-02-13open ↗

Quality score

C-
ValueGrowthProfitHealthMom.
ValueA+
GrowthF
ProfitabilityF
Financial healthC+
Momentum—
  • ✓Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
Revenue
$845M
+4.1% YoY
Net margin
-8.3%
ROE
-14.9%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$845M+4.1%
Net income-$70.3M-44.1%
Gross profit$291M+13.1%
Operating income-$27.8M-186.6%
Diluted EPS-$1.70-41.7%
Cash & equivalents$145M-14.0%
Total assets$1.11B-8.8%
Total liabilities$621M-7.4%
Stockholders' equity$473M-10.7%
Gross: 34.4%Op.: -3.3%L/E: 1.31x

Frequently asked

Is Varex Imaging Corp (VREX) a buy?
VREX currently carries a Sell rating with 3/5 conviction, derived from its latest SEC filings. Unprofitable (net margin -8.3%).
What is Varex Imaging Corp's quality score?
VREX scores 50.921568627450974/100 (grade C-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001681622, latest 10-Q filed 2026-05-07) · EODHD · as of 6/26/2026, 7:05:07 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-03-20
Kunkel Jay K.
Director
Sell4.51K @ $11.14$50.2K
2026-02-09
Kunkel Jay K.
Director
Exercise8.48K

Earnings history

beat/miss · move
2026-05-07Miss -1.8% est▼ -2.79%8-K ↗
2026-02-10Beat +40.0% est▲ +0.78%8-K ↗
2025-11-18Beat +98.7% est▲ +3.76%8-K ↗
2025-08-07Beat +404.2% est▲ +10.94%8-K ↗
2025-05-08—▲ +5.88%8-K ↗
2025-02-06—▲ +4.32%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Americans Are Cutting Spending on Everything Except Healthcare. These 2 Medical Device Stocks Under $30 Are Built to WinBullish
finance.yahoo.com· 2026-05-13
Varex Imaging (VREX) Q2 2026 Earnings TranscriptBullish
finance.yahoo.com· 2026-05-08
Varex Imaging Says Demand Steady Despite Geopolitics; Tariff Relief to Lift Margins, India Ramp AheadBullish
finance.yahoo.com· 2026-03-22
Varex Imaging Conference: CFO Highlights Tariff Pass-Through, India Factories, Cargo Systems & Photon CountingBullish
finance.yahoo.com· 2026-03-22
Sidoti Events, LLC's March Small-Cap Virtual ConferenceBullish
finance.yahoo.com· 2026-03-18
Varex Announces Successful Completion of Debt RefinancingBullish
finance.yahoo.com· 2026-03-16

Vs tracked universe

compare →

1043 tracked peers · median

EDGAR Score51 vs 67
Revenue growth4.1% vs 7.1%
Net margin-8.3% vs 10.5%
Return on equity-14.9% vs 12.3%
P/E— vs 25.5

News sentiment

EODHD · 2d
Bullish
+0.18
vs typical · 2 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.